The Food and Drug Administration (FDA) has approved Moderna’s mRNA flu vaccine, mFLUSIVA. The approval comes despite growing vaccine skepticism, especially toward mRNA vaccines following Covid-19. But research shows that this new vaccine can produce a stronger immune response and be made faster than the traditional flu vaccine.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Join 350,000+ subscribers and keep yourself informed with a selection of
